The network of the dialysis centers Fresenius NephroCare in Russia prepares for work in the system of marking of drugs

2019: System implementation of monitoring of medicines

On November 14, 2019 it became known that network of the dialysis centers Fresenius NephroCare in Russia are ready to work in the state information system of monitoring of the movement of medicines (GIS MDLP).

All dialysis centers of network which are in the territory of Russia are registered in the MDLP system and for November, 2019 are equipped with the necessary software.

In October, 2019 the network together with the operator of marking Center of Development of Perspective Technologies (CDPT) with assistance of integrator Raytskan Group held testing registrar of leaving which will be required since January 1, 2020 when fixation of an exit of medicine from turnover is obligatory.

Our centers carry out all preparatory work on marking implementation in advance, we selected the software product "1C: Medicine. Hospital drugstore" for test interaction with GIS MDLP. In October, 2019 we successfully held testing of the registrar of the leaving working in the network mode under management "1C: Medicine. Hospital drugstore". Therefore we can tell with confidence that we will provide accomplishment reported Kirill Obikhod, the Head of a project team, Fresenius Medical Care in Russia

During testing of the registrar of leaving in the dialysis centers necessary scenarios of an output from turnover of the used medicines were fulfilled. All data are correctly transferred to the MDLP system, confirmed Sergey Holkin, the head of Pharm, "Operator-TsRPT"

For November 14, 2019 Fresenius Medical Care in Russia manages 74 dialysis centers in 34 regions of the Russian Federation where more than 8,000 patients receive necessary treatment^[1].

Notes